Please login to the form below

Not currently logged in
Email:
Password:

Stallergenes

This page shows the latest Stallergenes news and features for those working in and with pharma, biotech and healthcare.

Merck gets US green light for allergy immunotherapy

Merck gets US green light for allergy immunotherapy

Grastek is the second allergy immunotherapy (AIT) product to be cleared for marketing in the US after Stallergenes' Oralair, which was approved last month.

Latest news

  • FDA backs a brace of allergy immunotherapies FDA backs a brace of allergy immunotherapies

    FDA backs a brace of allergy immunotherapies. Merck &Co and Stallergenes win drug approvals in US. ... Meanwhile for Stallergenes - with annual sales of around 250m - the upside could be significant.

  • Inducing immunity

    Hot on the heels of Grazax is Stallergenes' Oralair Grasses, which is expected to be launched in Europe in 2007.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Stallergenes appoints Christian Chavy CEO Stallergenes appoints Christian Chavy CEO

    Stallergenes appoints Christian Chavy CEO. He will replace Roberto Gradnik at the end of this month. ... Christian Chavy has been appointed CEO of French biopharmaceutical company Stallergenes and will take over from Roberto Gradnik at the end of this

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics